J9010 — Injection, alemtuzumab, 10 mg
J9010 is a HCPCS Level II code for injection, alemtuzumab, 10 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2015 and is not valid on new claims.
This code has been terminated
CMS terminated J9010 on December 31, 2015. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Not payable by Medicare
Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9010
- Long descriptor
- Injection, alemtuzumab, 10 mg
- Short descriptor
- Alemtuzumab injection
- Added
- January 1, 2003
- Terminated
- December 31, 2015
- BETOS
- O1E
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to J9010
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9010 is not quite right, the correct code is very often within a few positions of it.
- J8650Nabilone, oral, 1 mgterminated
- J8655Netupitant 300 mg and palonosetron 0.5 mg, oral
- J8670Rolapitant, oral, 1 mg
- J8700Temozolomide, oral, 5 mg
- J8705Topotecan, oral, 0.25 mg
- J8999Prescription drug, oral, chemotherapeutic, nos
- J9000Injection, doxorubicin hydrochloride, 10 mg
- J9003Leuprolide injectable (camcevi etm), 1 mg
- J9011Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015Injection, aldesleukin, per single use vial
- J9017Injection, arsenic trioxide, 1 mg
- J9019Injection, asparaginase (erwinaze), 1,000 iuterminated
- J9020Injection, asparaginase, not otherwise specified, 10,000 unitsterminated
- J9021Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022Injection, atezolizumab, 10 mg
- J9023Injection, avelumab, 10 mg
Questions about J9010
What is HCPCS code J9010?
J9010 is a HCPCS Level II code for injection, alemtuzumab, 10 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9010?
The CMS HCPCS file marks J9010 as "Not payable by Medicare". Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.
Is J9010 still valid?
No. J9010 was terminated on December 31, 2015 and should not be used on new claims.